| 000 | 00850nam a2200241Ia 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20220926030255.0 | ||
| 006 | a|||||r|||| 00| 0 | ||
| 007 | ta | ||
| 008 | 220923b |||||||| |||| 00| 0 eng d | ||
| 037 | _cGeneral Book | ||
| 040 |
_aRTL _cRTL _beng |
||
| 041 |
_2eng _aeng |
||
| 082 | _aX9(F56):75.73.N6, K7 | ||
| 100 |
_aFletcher F Marion _9333958 |
||
| 245 | 0 | _aMarket restraints in the retail drug industry | |
| 260 |
_aPhilandelphia _bUniversity Of Pennsylvania _c1967 |
||
| 300 |
_axvi,444p. Bib p. 425-33 Appendix p. 319-423 _ccm. |
||
| 490 | _aUniversity Of pennsylvania, Wharton School Of Finance And Commerce, Industrrial Research Unit Study. 43 | ||
| 650 |
_aPharmaceutical Industry _9230534 |
||
| 942 |
_hX9(F56):75.73.N6, K7 _cGB _2CC |
||
| 999 |
_c649166 _d649166 |
||